Literature DB >> 8063940

Raised concentration of plasma creatine kinase BB isoenzyme in myelodysplasia.

M Crook1, A Williams, A Sankaralingam, P Tutt.   

Abstract

A 72 year old woman presented with a suspected myocardial infarction. An echocardiograph showed no acute changes but her plasma creatine kinase (CK) activity was increased at 343 U/l (< 175 normal range). The apparent creatine kinase-MB activity by a CK-M subunit immunoinhibition assay was 350 U/l. In view of the discrepancy between the total creatine kinase and CK-MB activity plasma creatine kinase electrophoresis studies were performed which showed not only a band of creatine kinase-MM but also a band of creatine kinase-BB, 53% of the total creatine kinase activity. No band of CK-MB was seen. It later transpired that the woman had myelodysplasia. It is suggested that premalignant and malignant haematological conditions should be considered in patients with an unexplained increase in plasma CK-BB.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8063940      PMCID: PMC494754          DOI: 10.1136/jcp.47.6.552

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  3 in total

1.  Reactivation of serum creatine kinase isoenzyme BB in patients with malignancies.

Authors:  L B Abbott; J A Lott
Journal:  Clin Chem       Date:  1984-11       Impact factor: 8.327

2.  Non-M CK--a practical measure of creatine kinase isoenzymes in cancer patients.

Authors:  P G McGing; M Teeling; A McCann; F Kyne; D N Carney
Journal:  Clin Chim Acta       Date:  1990-03-15       Impact factor: 3.786

3.  Brain-type creatine kinase BB as a potential tumour marker--serum levels measured by radioimmunoassay in 1015 patients with histologically confirmed malignancies.

Authors:  E D Rubery; J F Doran; R J Thompson
Journal:  Eur J Cancer Clin Oncol       Date:  1982-10
  3 in total
  1 in total

1.  A case against the specificity of "cardiac" troponin-T.

Authors:  M Mahalingam; M E Ottlinger
Journal:  J Clin Pathol       Date:  1996-09       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.